KIMS signs 5-year O&M deal with Sarvottam Health Care for Kakinada hospital

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Krishna Institute of Medical Sciences signs 5-year O&M deal with Sarvottam Health Care
  • Company earns 9% fee on total net revenue from Kakinada hospital operations
  • Agreement includes option to extend for another five-year period
  • Hospital has 183 beds and 9,847.23 square metres built-up area
powered bylight_fuzz_icon
50589848

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Ltd has entered into an operations and management agreement with Sarvottam Health Care Private Limited to manage a healthcare facility in Kakinada, Andhra Pradesh.

Krishna Institute of Medical Sciences signed the deal on September 10, 2026, securing exclusive rights to operate and control the hospital for an initial term of five years. The agreement includes an option to extend for a further five-year period.

Deal Structure and Financial Terms

Under the terms of the agreement, Krishna Institute of Medical Sciences will receive a revenue fee of 9% of the total net revenue generated by the hospital. The contract defines net revenue as gross revenue billed to patients minus any concessions or discounts offered.

The arrangement is structured as a domestic operation with no share exchange or joint venture ratio involved. Krishna Institute of Medical Sciences will hold exclusive supervision and control over the hospital's operations, assuming sole responsibility for its management.

Facility Details and Strategic Rationale

Sarvottam Health Care Private Limited operates the "Trust Multi Speciality Hospital," which commenced operations in 2010 with 50 beds. The facility expanded significantly in 2021 with the inauguration of a state-of-the-art G+7 structure.

Facility Metric Details
Installed Capacity 183 beds
Built-up Area 9,847.23 square metres
Land Area 3,001.36 square yards
Location Kakinada, Andhra Pradesh

The company noted that this partnership enhances its presence in Andhra Pradesh, a region identified as having significant growth potential. Sarvottam Health Care benefits from Krishna Institute of Medical Sciences' operational expertise and medical supervision capabilities.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the transaction does not fall within related party transactions, and neither the promoters nor group companies have any interest in Sarvottam Health Care Private Limited.

Source:

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+2.54%-4.72%+11.51%+3.29%+209.18%

How is the 9% revenue fee model expected to impact Krishna Institute of Medical Sciences' profit margins compared to its existing asset-heavy hospital operations?

What specific operational improvements or patient volume growth targets has Krishna Institute set for the Kakinada facility in the first year of management?

Does this agreement signal a broader strategic shift for Krishna Institute towards a lighter, management-contract-based expansion model across other high-potential regions in India?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like19
dislike

KIMS Ltd to host institutional investor meet on September 10

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Krishna Institute of Medical Sciences Limited hosts investor meet on September 10, 2026
  • Event begins at 2:30 pm at KIMS Mahadevpura facility
  • Hosted by Emkay Global with group and one-on-one sessions
  • Discussions limited to publicly available information only
powered bylight_fuzz_icon
50329424

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited will host an institutional investor meeting on September 10, 2026. The event aims to facilitate interaction between company officials and analysts.

The meeting is scheduled for Thursday, September 10, 2026, starting at 2:30 pm. It will be hosted by Emkay Global and held at the KIMS Mahadevpura facility.

Meeting Details

The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The format includes both group and one-on-one sessions conducted in person.

Date / Time Event Type / Mode Venue
September 10, 2026, 2:30 pm Institutional Investor Meeting hosted by Emkay Global Group Meeting / One on One – In Person KIMS Mahadevpura

Disclosure Notes

Discussions during the meeting will rely solely on publicly available information. The company confirmed that no unpublished price-sensitive information will be shared. The schedule remains subject to change due to exigencies on the part of participants or the company.

Nagajyanthi J. R, Company Secretary and Compliance Officer, signed the disclosure on September 7, 2026.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%+2.54%-4.72%+11.51%+3.29%+209.18%

How might the strategic priorities discussed by KIMS management at this meeting influence their capital allocation for hospital expansions in 2027?

What specific operational metrics or growth targets is Emkay Global likely to probe regarding KIMS's post-pandemic recovery trajectory?

Could insights from this investor meeting signal any potential changes in dividend policy or share buyback plans for the upcoming fiscal year?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like18
dislike

More News on Krishna Institute of Medical Sciences

1 Year Returns:+3.29%